SIGA Reports Financial Results for Three and Six Months Ended June 30, 2021

By Dr. Matthew Watson

- Approximately $7 Million in International Sales of Oral TPOXX® in the Second Quarter –

Read more here:
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2021

Related Post


categoriaGlobal News Feed commentoComments Off on SIGA Reports Financial Results for Three and Six Months Ended June 30, 2021 | dataAugust 6th, 2021

About...

This author published 4012 posts in this site.

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

Comments are closed.





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research